Clinical Trial Site — Philadelphia, Pennsylvania

Clinical Trial Site is a clinical research site located in Philadelphia, Pennsylvania, United States 19107.

Crixeo Health Trust Score: 82/100 (GOOD). This profile has not yet been claimed by the site owner.

Clinical Trial Site has participated in 34 clinical trials with 19 currently active.

Therapeutic areas: Acute Hepatic Porphyria, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy, Acute Intermittent Porphyria.

Sponsors: Alnylam Pharmaceuticals, Priovant Therapeutics, Inc., Ultragenyx Pharmaceutical Inc.

Sponsor Feasibility Report

Trust Score: 82/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Clinical Trial Site?

Clinical Trial Site has a Crixeo Trust Score of 82/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Clinical Trial Site conducted?

Clinical Trial Site has 34 clinical trials on record, with 19 currently active. Their work covers Acute Hepatic Porphyria, Transthyretin Amyloidosis (ATTR) With Cardiomyopathy, Acute Intermittent Porphyria.

Is Clinical Trial Site accredited by Crixeo Health?

Yes — Clinical Trial Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Clinical Trial Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.